Jensen Ronald W, Rivest Jason, Li Wei, Vissa Varalakshmi
Department of Microbiology, Immunology and Pathology, Colorado State University, USA.
J Vis Exp. 2011 Jul 15(53):e3104. doi: 10.3791/3104.
The study of the transmission of leprosy is particularly difficult since the causative agent, Mycobacterium leprae, cannot be cultured in the laboratory. The only sources of the bacteria are leprosy patients, and experimentally infected armadillos and nude mice. Thus, many of the methods used in modern epidemiology are not available for the study of leprosy. Despite an extensive global drug treatment program for leprosy implemented by the WHO, leprosy remains endemic in many countries with approximately 250,000 new cases each year. The entire M. leprae genome has been mapped and many loci have been identified that have repeated segments of 2 or more base pairs (called micro- and minisatellites). Clinical strains of M. leprae may vary in the number of tandem repeated segments (short tandem repeats, STR) at many of these loci. Variable number tandem repeat (VNTR) analysis has been used to distinguish different strains of the leprosy bacilli. Some of the loci appear to be more stable than others, showing less variation in repeat numbers, while others seem to change more rapidly, sometimes in the same patient. While the variability of certain VNTRs has brought up questions regarding their suitability for strain typing, the emerging data suggest that analyzing multiple loci, which are diverse in their stability, can be used as a valuable epidemiological tool. Multiple locus VNTR analysis (MLVA) has been used to study leprosy evolution and transmission in several countries including China, Malawi, the Philippines, and Brazil. MLVA involves multiple steps. First, bacterial DNA is extracted along with host tissue DNA from clinical biopsies or slit skin smears (SSS). The desired loci are then amplified from the extracted DNA via polymerase chain reaction (PCR). Fluorescently-labeled primers for 4-5 different loci are used per reaction, with 18 loci being amplified in a total of four reactions. The PCR products may be subjected to agarose gel electrophoresis to verify the presence of the desired DNA segments, and then submitted for fluorescent fragment length analysis (FLA) using capillary electrophoresis. DNA from armadillo passaged bacteria with a known number of repeat copies for each locus is used as a positive control. The FLA chromatograms are then examined using Peak Scanner software and fragment length is converted to number of VNTR copies (allele). Finally, the VNTR haplotypes are analyzed for patterns, and when combined with patient clinical data can be used to track distribution of strain types.
麻风病传播的研究格外困难,因为其病原体麻风分枝杆菌无法在实验室中培养。该细菌的唯一来源是麻风病患者、经实验感染的犰狳和裸鼠。因此,现代流行病学中使用的许多方法并不适用于麻风病研究。尽管世界卫生组织实施了广泛的全球麻风病药物治疗计划,但麻风病在许多国家仍然流行,每年约有25万新病例。麻风分枝杆菌的全基因组已被绘制,并且已鉴定出许多具有2个或更多碱基对重复片段的基因座(称为微卫星和小卫星)。麻风分枝杆菌的临床菌株在许多这些基因座处的串联重复片段(短串联重复序列,STR)数量可能有所不同。可变数目串联重复序列(VNTR)分析已被用于区分麻风杆菌的不同菌株。一些基因座似乎比其他基因座更稳定,重复数目的变化较少,而其他基因座似乎变化更快,有时在同一患者中也是如此。虽然某些VNTR的变异性引发了关于其用于菌株分型的适用性的问题,但新出现的数据表明,分析多个稳定性不同的基因座可作为一种有价值的流行病学工具。多位点VNTR分析(MLVA)已被用于研究包括中国、马拉维、菲律宾和巴西在内的多个国家的麻风病进化和传播情况。MLVA涉及多个步骤。首先,从临床活检或皮肤涂片(SSS)中提取细菌DNA以及宿主组织DNA。然后通过聚合酶链反应(PCR)从提取的DNA中扩增所需的基因座。每个反应使用针对4 - 5个不同基因座的荧光标记引物,总共四个反应中扩增18个基因座。PCR产物可进行琼脂糖凝胶电泳以验证所需DNA片段的存在,然后使用毛细管电泳进行荧光片段长度分析(FLA)。来自犰狳传代细菌的DNA,每个基因座具有已知数量的重复拷贝,用作阳性对照。然后使用Peak Scanner软件检查FLA色谱图,并将片段长度转换为VNTR拷贝数(等位基因)。最后,分析VNTR单倍型的模式,并与患者临床数据相结合时可用于追踪菌株类型的分布。